Biomaterial Database

Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. 1990

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Third Department of Medicine, Nagoya University School of Medicine, Japan.

Ursodeoxycholic acid treatment (600 mg/day) was evaluated in a patient with asymptomatic primary sclerosing cholangitis. Serum levels of biliary enzymes decreased to normal ranges within 1 month's treatment and remained normal for 26 months. Serum chenodeoxycholic acid had been replaced by ursodeoxycholic acid, and hepatic copper metabolism, assessed by x-ray probe analysis, improved during the treatment. However, neither biliary tract sclerosis nor portal tract pathology changed with the treatment. These observations suggest that ursodeoxycholic acid protects the liver in primary sclerosing cholangitis by improving the metabolism of bile acid and copper.

UI	MeSH Term	Description	Entries
D008099	Liver	A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.	Livers
D008297	Male		Males
D003300	Copper	A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.	Copper-63,Copper 63
D003840	Deoxycholic Acid	A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.	Deoxycholate,Desoxycholic Acid,Kybella,Choleic Acid,Deoxycholic Acid, 12beta-Isomer,Deoxycholic Acid, 3beta-Isomer,Deoxycholic Acid, 5alpha-Isomer,Deoxycholic Acid, Disodium Salt,Deoxycholic Acid, Magnesium (2:1) Salt,Deoxycholic Acid, Monoammonium Salt,Deoxycholic Acid, Monopotassium Salt,Deoxycholic Acid, Monosodium Salt,Deoxycholic Acid, Sodium Salt, 12beta-Isomer,Dihydroxycholanoic Acid,Lagodeoxycholic Acid,Sodium Deoxycholate,12beta-Isomer Deoxycholic Acid,3beta-Isomer Deoxycholic Acid,5alpha-Isomer Deoxycholic Acid,Deoxycholate, Sodium,Deoxycholic Acid, 12beta Isomer,Deoxycholic Acid, 3beta Isomer,Deoxycholic Acid, 5alpha Isomer
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D001647	Bile Acids and Salts	Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.	Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D014580	Ursodeoxycholic Acid	An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.	Deoxyursocholic Acid,3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid,Cholit-Ursan,Cholofalk,Delursan,Destolit,Sodium Ursodeoxycholate,Urdox,Ursacholic Acid,Urso,Urso Heumann,Ursobilane,Ursochol,Ursodiol,Ursofalk,Ursogal,Ursolite,Ursolvan,3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid,Acid, Deoxyursocholic,Acid, Ursacholic,Acid, Ursodeoxycholic,Ursodeoxycholate, Sodium
D015209	Cholangitis, Sclerosing	Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.	Cholangiitis, Sclerosing,Cholangitis, Primary Sclerosing,Primary Sclerosing Cholangitis,Sclerosing Cholangitis,Cholangiitides, Sclerosing,Cholangitides, Primary Sclerosing,Cholangitides, Sclerosing,Primary Sclerosing Cholangitides,Sclerosing Cholangiitides,Sclerosing Cholangiitis,Sclerosing Cholangitides,Sclerosing Cholangitides, Primary,Sclerosing Cholangitis, Primary

Related Publications

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

[Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].

November 1997, Ugeskrift for laeger,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Ursodeoxycholic acid for primary sclerosing cholangitis.

July 1990, Journal of hepatology,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Ursodeoxycholic acid in primary sclerosing cholangitis.

March 2012, Alimentary pharmacology & therapeutics,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

[Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].

July 1989, Zeitschrift fur Gastroenterologie. Verhandlungsband,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.

March 1997, The New England journal of medicine,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.

May 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine.

August 1998, Journal of gastroenterology and hepatology,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.

October 2011, Alimentary pharmacology & therapeutics,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Promises, promises: ursodeoxycholic acid for primary sclerosing cholangitis.

March 1993, Gastroenterology,

H Hayashi, and T Higuchi, and H Ichimiya, and N Hishida, and N Sakamoto

Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis.

January 1994, Scandinavian journal of gastroenterology. Supplement,